Tryp Therapeutics Partners with Alcami for Proprietary Formulations
Ryan Allway May 25th, 2021 Psychedelics San Diego, California–(Newsfile Corp. – May 25, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) (“Tryp”), a pharmaceutical company focused on developing compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today an agreement with Alcami Corporation (“Alcami”),... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )